Wellington Management Group LLP Mersana Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 618,305 shares of MRSN stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

618,305

Previous 532,866 16.03%

Holding current value

$1.28 Million

Previous $1.07 Million 9.06%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $105,089 - $192,237	85,439 Added 16.03%	618,305 $1.17 Million
Q2 2024 Aug 13, 2024	SELL	$2.0 - $4.45 $3,504 - $7,796	-1,752 Reduced 0.33%	532,866 $1.07 Million
Q1 2024 May 15, 2024	BUY	$2.16 - $5.94 $1.15 Million - $3.18 Million	534,618 New	534,618 $2.4 Million
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $17 Million - $30.1 Million	-4,536,434 Reduced 90.42%	480,644 $1.92 Million
Q4 2021 Feb 11, 2022	SELL	$5.48 - $9.86 $5.43 Million - $9.76 Million	-990,297 Reduced 16.48%	5,017,078 $31.2 Million
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $7.45 Million - $12.6 Million	-869,961 Reduced 12.65%	6,007,375 $56.7 Million
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $9.29 Million - $12.6 Million	699,543 Added 11.32%	6,877,336 $93.4 Million
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $23.3 Million - $40.4 Million	1,524,727 Added 32.77%	6,177,793 $100 Million
Q4 2020 Feb 12, 2021	BUY	$16.84 - $27.59 $14.5 Million - $23.8 Million	862,234 Added 22.75%	4,653,066 $124 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $14.7 Million - $23.3 Million	904,705 Added 31.35%	3,790,832 $70.6 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $15 Million - $67 Million	2,865,090 Added 13619.29%	2,886,127 $67.5 Million
Q4 2019 Feb 11, 2020	BUY	$1.45 - $6.73 $30,503 - $141,579	21,037 New	21,037 $121,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $201M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Mersana Therapeutics, Inc. Transaction History